LoadingLoadingLoadingThe quick read
Latest quote
Net selling: insiders sold $2.7M and bought $0 on the open market in 90 days (SEC Form 4). Congress: net selling of $32K to $130K in 180 days.
Analyst target and ratings are on paid plans
See the 12-month consensus target and the buy/hold/sell rating split.
Unlock the full resultsNet selling: insiders sold $2.7M and bought $0 of EMR stock on the open market in the 90 days to Oct 18, 2026, according to SEC Form 4 filings. The largest was Karsanbhai, Surendralal Lanca (President & CEO), who sold $1.6M. The latest filing was on Aug 12, 2026.
Rep. Kevin Hern (R) sold $15K to $50K on Sep 17, 2026, disclosed 26 days later. Rep. Kevin Hern (R) sold $1K to $15K on Sep 14, 2026, disclosed 11 days later. Rep. Kevin Hern (R) sold $15K to $50K on Sep 14, 2026, disclosed 11 days later. Rep. Richard Dean McCormick (R) sold $1K to $15K on Jul 30, 2026, disclosed 15 days later. In total, 2 members disclosed 4 EMR trades with trade dates in the last 180 days, filed a median 13 days after trading.
This summary uses filings available on Oct 18, 2026. Insiders must report trades to the SEC within 2 business days, members of Congress have up to 45 days to disclose a trade, and funds file 13F holdings up to 45 days after each quarter ends, so the latest moves may not be public yet.
8 funds hold a position and insiders have been net selling.
Buys/Adds (1)
Point72
$79.8M
bought
Sells/Trims (2)
Squarepoint
$42.2M
trimmed
Bridgewater
$12.3M
trimmed
No tracked top-trader positions in EMR right now.
Live Hyperliquid positioning - not every stock is covered
Last report
Aug 4, 2026
Financial period
Q3 FY2026
Adjusted EPS
$1.68 expected
Revenue
$4.80B expected
| Period ending | Reported | EPS / estimate | EPS surprise | Revenue / estimate | Rev. surprise |
|---|---|---|---|---|---|
| Jun 30, 2026 | Oct 13, 2026 | $1.71 / $1.68Yahoo Finance | +1.96% beat | $4.87B / $4.80B | +1.46% beat |
| Mar 31, 2026 | May 5, 2026 | $1.54 / $1.53Yahoo Finance | +0.44% in line | Unavailable | Unavailable |
| Dec 31, 2025 | Feb 3, 2026 | $1.46 / $1.41Yahoo Finance | +3.39% beat | Unavailable | Unavailable |
| Sep 30, 2025 | Nov 5, 2025 | $1.62 / $1.62Yahoo Finance | +0.28% in line | Unavailable | Unavailable |
| Jun 30, 2025 | Aug 6, 2025 | $1.52 / $1.51Alpha Vantage | +0.66% in line | Unavailable | Unavailable |
| Mar 31, 2025 | May 7, 2025 | $1.48 / $1.41Alpha Vantage | +4.96% beat | Unavailable | Unavailable |
| Dec 31, 2024 | Feb 5, 2025 | $1.38 / $1.28Alpha Vantage | +7.81% beat | Unavailable | Unavailable |
| Sep 30, 2024 | Nov 5, 2024 | $1.48 / $1.47Alpha Vantage | +0.68% in line | Unavailable | Unavailable |
EPS uses Yahoo Finance where available, then Alpha Vantage or verified release comparisons. Revenue uses company releases and saved estimates.
Estimates as of Oct 17, 2026
EPS expected
$1.80 to $1.88
Revenue expected
22 analysts
Last 30 days
Split both ways
| USD | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| What came in | ||||
| Revenue | $4.86B | $4.35B | $4.56B | $4.87B |
| Cost of what it sold | $2.34B | $2.04B | $2.14B | $2.22B |
| Gross profit | $2.52B | $2.31B | $2.42B | $2.65B |
| What it spent | ||||
| Sales and admin | $1.33B | $1.24B | $1.32B | $1.34B |
| Other operating costs | $207.0M | $205.0M | $205.0M | $311.0M |
| Total operating expenses | $1.54B | $1.45B | $1.52B | $1.65B |
| What was left | ||||
| Operating profit | $982.0M | $864.0M | $901.0M | $1.00B |
| Interest on debt | $242.0M | $116.0M | $110.0M | $85.0M |
| Profit before tax | $796.0M | $775.0M | $793.0M | $916.0M |
| Tax | $160.0M | $169.0M | $175.0M | $198.0M |
| Net profit | $636.0M | $605.0M | $618.0M | $718.0M |
| EBITDA | $1.42B | $1.25B | $1.27B | $1.21B |
This stock is in a strong uptrend.
Trend
Strong uptrend
100 / 100
RSI 14
20D volatility
52-week range
20D support
20D resistance
Returns
Price vs moving averages
Volume pace
